Scaffold Proteins in Fibrotic Diseases of Visceral Organs

Area of Science:

• Biochemistry
• Cell Biology
• Pathology

Background:

• Fibrosis involves excessive extracellular matrix (ECM) deposition, leading to organ dysfunction and failure.
• Current therapeutic options for fibrosis are limited despite advances in understanding its molecular basis.
• Scaffold proteins are increasingly recognized as critical regulators in fibrosis progression.

Purpose of the Study:

• To review the role of scaffold proteins in regulating fibrosis across multiple organs.
• To discuss emerging therapeutic strategies targeting scaffold proteins for fibrosis management.
• To highlight the integration of mechanotransduction, inflammatory, and developmental signals by scaffold proteins.

Main Methods:

• Literature review synthesizing recent findings on scaffold protein functions.
• Analysis of scaffold protein roles in ECM remodeling, cytoskeletal organization, and cell migration.
• Exploration of therapeutic interventions including small-molecule inhibitors, peptides, biologics, and gene therapy.

Main Results:

• Scaffold proteins act as molecular platforms, coordinating key signaling pathways in fibrosis.
• These proteins integrate profibrotic and antifibrotic signals, influencing disease progression.
• Targeting scaffold proteins presents a unique therapeutic window for fibrotic diseases.

Conclusions:

• Scaffold proteins are pivotal in linking various signaling pathways relevant to fibrosis.
• Modulating scaffold protein activity offers promising therapeutic avenues for treating fibrotic conditions.
• Novel strategies targeting scaffold proteins could potentially manage and reverse organ fibrosis.